Publication:
Biologic tumor behavior in pilocytic astrocytomas

dc.contributor.authorBOZKURT, SÜHEYLA
dc.contributor.authorsBelirgen, Muhittin; Berrak, Su Gulsun; Ozdag, Hilal; Bozkurt, Suheyla Uyar; Eksioglu-Demiralp, Emel; Ozek, M. Memet
dc.date.accessioned2022-03-12T18:07:31Z
dc.date.accessioned2026-01-11T15:29:33Z
dc.date.available2022-03-12T18:07:31Z
dc.date.issued2012
dc.description.abstractThe aim is to describe the behavior of pilocytic astrocytoma (PAs) and its effects on patient prognosis by using flow cytometric, immunohistochemical and cytogenetic methods. We also aim to find out whether there is any difference between differently localized tumors by the above mentioned analyses. We studied DNA index, expression of p53, p16, pRb, MMAC/PTEN1, VEGF, MIB-1 index and chromosomal anomalies which can be detected by array comparative genomic hybridization (CGH) technique. We analyzed the association of the results of these studies with clinical prognosis and tumor localization. We included 53 patients (18 cerebellar, 20 chiasmatic/hypothalamic and 15 hemispheric). Samples were studied from paraffin embedded tumors. We found that PAs are mostly diploid and ploidy pattern does not affect the prognosis. The expression of p53, p16, pRb, MMAC/PTEN1 and VEGF was not significantly different between different localizations and could not predict the prognosis. Frequently seen copy number aberrations (CNAs) are: amplification in 1p36.33, 2p11.2, 9p11.2, 9q12, 16p11.2, 19q13.12-q13.2, Xp22.2-p21.3, Xp11.3-p11.22, Xq11.1-q12, Xq13.1, Xq21.1-q21.31, Xq22.3, Xq26.3 and homozygous deletion in 2p11.2, 8p23.1, 16p12.3. Among them, 2p11.2 amp, 9p11.2 amp and 1p36.21 hom del were correlated with prognosis. Moreover, we found a significant correlation between 16p11.2 amp and tumor localization. Differently localized PAs have different properties which make them behave with different biological aggressiveness. PAs demonstrate a significant amount of CNAs that can be detected by a high-resolution study. However, tumor suppressor genes p53, p16, pRb, MMAC/PTEN1 and expression patterns do not play a significant role in PAs.
dc.identifier.doi10.1007/s00381-011-1676-6
dc.identifier.eissn1433-0350
dc.identifier.issn0256-7040
dc.identifier.pubmed22246337
dc.identifier.urihttps://hdl.handle.net/11424/231031
dc.identifier.wosWOS:000300663300010
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.ispartofCHILDS NERVOUS SYSTEM
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPilocytic astrocytomas
dc.subjectImmunohistochemistry
dc.subjectTumor suppressor proteins
dc.subjectFlow cytometry
dc.subjectMicroarray
dc.subjectCGH
dc.subjectCopy number aberration
dc.subjectCOMPARATIVE GENOMIC HYBRIDIZATION
dc.subjectENDOTHELIAL GROWTH-FACTOR
dc.subjectRETINOBLASTOMA PROTEIN EXPRESSION
dc.subjectBENIGN CEREBELLAR ASTROCYTOMA
dc.subjectMIB-1 LABELING INDEX
dc.subjectBRAIN-TUMORS
dc.subjectPTEN GENE
dc.subjectGLIOBLASTOMA-MULTIFORME
dc.subjectCEREBRAL HEMISPHERES
dc.subjectDIFFUSE ASTROCYTOMAS
dc.titleBiologic tumor behavior in pilocytic astrocytomas
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage389
oaire.citation.issue3
oaire.citation.startPage375
oaire.citation.titleCHILDS NERVOUS SYSTEM
oaire.citation.volume28

Files